GH
Guardant Health Inc
165.60$
-1.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 74.9% | 75.4% | 76.8% | 80.2% | 79.7% | 71.0% | 69.0% | 66.3% | 64.9% | 72.8% | 71.4% | 71.4% | |
| 25.4% | 63.5% | 66.2% | 64.3% | 44.7% | 35.4% | 52.0% | 47.2% | 45.4% | 18.8% | 51.7% | 55.1% | |
| 64.3% | 65.4% | 66.2% | 64.3% | 64.9% | 56.5% | 52.0% | 47.2% | 45.4% | 59.7% | 57.6% | 55.1% | |
| 4.9% | 5.0% | 5.0% | 6.2% | 5.7% | 7.4% | 8.6% | 9.8% | 9.1% | 6.8% | 7.2% | 7.5% | |
| 4.3% | 3.5% | 3.7% | 4.2% | 4.7% | 4.8% | 5.7% | 6.3% | 7.1% | 4.3% | 4.4% | 5.5% | |
| 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | 3.8% | 4.0% | 4.0% | |
| 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.4% | 0.4% | 1.3% | 1.3% | 1.3% | |
| 87.3% | 91.1% | 96.0% | 100.1% | 103.9% | 109.4% | 118.7% | 122.9% | 127.8% | 104.9% | 109.5% | 111.7% | |
| 12.6% | 11.5% | 12.9% | 12.5% | 12.8% | 15.2% | 16.8% | 17.9% | 18.6% | 15.0% | 15.3% | 17.7% | |
| 1.5% | 1.6% | 1.6% | 1.7% | 1.8% | 2.0% | 2.2% | 2.0% | 2.1% | 1.4% | 1.5% | 1.5% | |
| 4.3% | 2.9% | 2.2% | 2.6% | 1.0% | 2.6% | 3.7% | 3.4% | 1.6% | 2.7% | 3.9% | 4.9% | |
| 63.4% | 63.8% | 66.9% | 70.9% | 74.2% | 76.9% | 83.0% | 83.7% | 87.3% | 74.7% | 78.5% | 78.6% | |
| 12.7% | 8.9% | 4.0% | -0.1% | -3.9% | -9.4% | -18.7% | -22.9% | -27.8% | -4.9% | -9.5% | -11.7% | |
| -108.8% | -119.9% | -132.4% | -146.6% | -160.3% | -173.5% | -198.9% | -208.2% | -224.5% | -148.7% | -162.2% | -168.7% | |
| 6.6% | 6.6% | 7.1% | 7.6% | 8.0% | 8.3% | 9.2% | 9.3% | 9.8% | 6.4% | 6.9% | 6.9% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.